| MNOV Stock | | | USD 2.00 0.05 2.56% |
MediciNova financial indicator trend analysis is infinitely more than just investigating MediciNova recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MediciNova is a good investment. Please check the relationship between MediciNova Capital Surpluse and its Net Receivables accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MediciNova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in persons.
For more information on how to buy MediciNova Stock please use our
How to Invest in MediciNova guide.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
MediciNova Capital Surpluse account and
Net Receivables. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between MediciNova's Capital Surpluse and Net Receivables is -0.37. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Net Receivables in the same time period over historical financial statements of MediciNova, assuming nothing else is changed. The correlation between historical values of MediciNova's Capital Surpluse and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of MediciNova are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Capital Surpluse i.e., MediciNova's Capital Surpluse and Net Receivables go up and down completely randomly.
Correlation Coefficient | -0.37 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Most indicators from MediciNova's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MediciNova current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MediciNova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in persons.
For more information on how to buy MediciNova Stock please use our
How to Invest in MediciNova guide.At this time, MediciNova's
Tax Provision is fairly stable compared to the past year.
Enterprise Value is likely to climb to about 82.8
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 4.7
M in 2024.
When running MediciNova's price analysis, check to
measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to
predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.